Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Henrik Bergentoft — CFO

Roles

Oncopeptides AB Stockholm
CFO
16.09.2025 – 16.03.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
16.03.2026Oncopeptides AB Stockholm
New shares (subscription)
14,258SEK 1.55
SEK 22,099.90
↗
16.09.2025Oncopeptides AB Stockholm
New shares (subscription)
5,184SEK 3.20
SEK 16,588.80
↗